Jurnal Teknologi dan Industri Pangan (Jun 2018)
AMYLASE INHIBITION AND FREE RADICAL SCAVENGING ACTIVITIES OF WHITE TURMERIC EXTRACT AND FRACTIONS
Abstract
Diabetes is the most common endocrinal disorder characterized by hyperglycemia and long-term complications. Recently, the development of antidiabetic drugs have focused on natural products with va-rious mechanisms such as the inhibition of α-amylase. White turmeric (Curcuma mangga Val) from Zinge-beraceae family has been reported to have antidiabetic activities, thus the aim of this study was to eva-luate the effects of C. mangga extracts and fractions as antioxidant and antidiabetic agents through sca-venging activities and inhibition of α-amylase. In this study, the antidiabetic activities of four fractions of C. mangga extracts (water, hexane, ethyl acetate, butanol), a C. mangga extract and butylated hydroxyto-luene/antioxidant standard were measured using α-amylase activity assay, while the antioxidant activities of the fractions were measured using 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2'-azino-bis (3-ethylben-zothiazoline-6-sulfonic acid) (ABTS) assays. These fractions were also compared to an antidiabetic drug, acarbose, as a control and butylated hydroxytoluene (BHT), a synthetic antioxidant. For the antioxidant assay, the butanol fraction of C. mangga (BCM) showed the highest ABTS-reducing activity (IC50= 24.23 ±2.77 μg/mL), while with the DPPH assay, the ethyl acetate fraction (EACM) had the highest activity (IC50 = 83.95±2.89 μg/mL) as compared to the other fractions and C. mangga extract, but the activities were lower than that of BHT. For the antidiabetic assay, C. mangga extract (CME) had the highest α-amylase inhibitory activity (IC50 = 363.67 µg/mL) among other fractions, although lower than acarbose. Curcuma mangga fractions (BCM and EACM) had antioxidant activities, while C. mangga extract (CME) had a po-tential as an antidiabetic by in vitro studies. Further in vivo studies is needed to confirm these findings.
Keywords